Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases.
Ane Rivas-MachoMaría V RomeoElisabeth RacklesGarbiñe OlabarriaJuan Manuel Falcon-PerezJesús Berganza-GrandaAitziber L CortajarenaFelipe Goñi-de-CerioPublished in: Expert review of molecular diagnostics (2023)
The potential of Hsp90 as a biomarker disease has been demonstrated in several studies in relation to infectious diseases and especially cancer. However, further research in this field is still needed, mainly to validate in statistically significant clinical studies that the detection of Hsp90 protein allows the diagnosis of some cancers at an early stage and also that it can act as a biomarker for monitoring the efficacy of their therapies.